Abstract
Recommendations regarding the current therapy of primary brain lymphoma (NHL-CNS) take into account the occurrence of this tumor in immunocompetent and immumosuppressed hosts. Immunohistochemical evaluation of biopsy material or spinal fluid provides the diagnosis in 90% of patients. For the immunocompetent, pre-irradiation intra-venous or intra-arterial chemotherapy with Methotrexate alone or in combination with other agents is provided to treat tumor within multiple brain sites. Subarachnoid deposits are treated with Methotrexate by intrathecal administration. Radiation is provided after chemotherapy and for the treatment of vitreal/retinal deposits or symptomatic lesions within the spinal axis. The therapy of recurrent NHL-CNS makes use of intravenous Methotrexate or high dose Cytosine Arabinoside. Immunosuppressed patients respond to reduction of immunosuppressive medication. The therapy of NHL-CNS in the AIDS patient makes use of corticosteroids followed by cranial irradiation. A discussion of emerging trends in the therapy of NHL-CNS in the AIDS and non-AIDS population is provided.
Similar content being viewed by others
References
Hochberg FH, Miller DC: Primary central nervous system lymphoma. J Neurosurg 68: 835–853, 1988
Benjamin I, Case MES: Primary reticulum-cell sarcoma (microglioma) of the brain with massive cardiac metastasis. J Neurosurg 53: 714–716, 1980
Berry MP, Simpson WJ: Radiation therapy in the management of primary malignant lymphoma of the brain. Int J Rad Oncol Biol Phys 7: 55–59, 1981
Henry JM, Heffner RR Jr, Dillard SH et al.: Primary malignant lymphomas of the central nervous system. Cancer 34: 1293–1302, 1974
Homo-Delarche F: Glucocorticoid receptors and steroid sensitivity in normal and neoplastic human lymphoid tissues. A review. Cancer Res 44: 431–437, 1984
Williams RS, Crowell RM, Fisher CM et al.: Clinical and radiologic remission in reticulum cell sarcoma of the brain. Arch Neurol 36: 206–210, 1979
Ruff RL, Petito CK, Rawlinson DG: Primary cerebral lymphoma mimicking multiple sclerosis. Arch Neurol 36: 598, 1979
Singh A, Stobos RJ, Singh BM et al.: Steroid-induced remissions in CNS lymphoma. Neurology 32: 1267–1271, 1982
Vaquero J, Martinez R, Rossi E et al.: Primary cerebral lymphoma: the ‘ghost tumor’. Case report. J Neurosurg 60: 174–176, 1984
Bush RJ, Gaspodarowicz M, Sturgeon J et al.: Radiation therapy of localized non-Hodgkin's lymphoma. Cancer Treat Rep 61: 1129–1136, 1977
Fuks Z, Kaplan HJ: Recurrence rates following radiation therapy of nodular and diffuse malignant lymphomas. Radiology 108: 675–684, 1973
Loeffler JS, Ervin TJ, Mauch P et al.: Primary lymphoma of the central nervous system: patterns of failure and factors that influence survival. J Clin Oncol 3: 490–494, 1985
Mackintosh FR, Colby RV, Podolsky WJ et al.: Central nervous system involvement in non-Hodgkin's lymphoma: an analysis of 105 cases. Cancer 49: 586–595, 1982
Murray K, Kun L, Cox J: Primary malignant lymphoma of the central nervous system. J Neurosurg 65: 600–607, 1987
Schaumberg HH, Plank CR, Adams RD: The reticulum cell sarcoma-microglioma group of brain tumours. A consideration of their clinical features and therapy. Brain 95: 199–212, 1972
Littman P, Wang CC: Reticulum cell sarcoma of the brain. Cancer 35: 1412–1420, 1975
Nelson DF, Martz KL, Bonner H et al.: Definitive radiation therapy in the treatment of primary non-Hodgkin's lymphoma of the central nervous system,non-AIDS related; report of the RTOG 8315. J Neurosurg (in press)
Bogdahn U, Bogdahn S, Mertens HG et al.: Primary non-Hodgkin's lymphomas of the CNS. Acta Neurol Scand 73: 602–614, 1986
Sagerman RH, Cassady JR, Chang CH: Radiation therapy for intracranial lymphoma. Radiology 88: 552–554, 1967
Cox J, Koehl RH, Turner WM et al.: Irradiation in the local control of malignant lymphoreticulum tumors (non-Hodgkin's malignant lymphoma). Radiology 112: 179–185, 1974
Foncin JF, Faucher JN: Primary and borderline brain lymphosarcoma; A neuropathological review of nine cases. Acta Neuropathol 6: 107–113, 1975
Gonzalez DG, Schuster-Uitterhoue ALJ: Primary non-Hodgkin's lymphoma of the central nervous system. Results of radiotherapy in 15 cases. Cancer 51: 2048–2052, 1983
Rosen ST, Zimmer AM, Goldman-Leikin R et al.: Radioimmunodetection and radioimmunotherapy of cutaneous T cell lymphomas using a 131 I labeled monoclonal antibody; an Illinois cancer counsel study. J Clin Oncol 5: 562–573, 1987
Lashford LS, Davies AG, Richardson RB et al.: A pilot study of 131 I monoclonal antibodies in the therapy of leptomeningeal tumors. Cancer 61: 857–868, 1988
Loeffler JS, Alexander E III: The role of stereotactic radiosurgery in the management of intracranial tumors. Oncology 4: 21–31, 1990
Larson DA, Leibel SA, Gutin PH et al.: Stereotactic irradiation of brain tumors. Cancer (in press)
Skarin AT, Zuckerman KS, Pitman SW et al.: High dose methotrexate with folinic acid in the treatment of advanced non-Hodgkin's lymphoma including CNS involvement. Blood 50: 1039–1047, 1977
Skarin AT, Canellos GP, Rosenthal DS et al.: Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD). J Clin Oncol 1: 91–98, 1983
Herbst KD, Corder MP, Justice GR: Successful therapy with methotrexate of the multicentric mixed lymphoma of the central nervous system. Cancer 38: 1476–1478, 1976
Ervin T, Canellos GP: Successful treatment of recurrent primary central nervous system lymphoma with high dose methotrexate. Cancer 45: 1556–1557, 1980
Abelson HT, Kufe DW, Skarin AT et al.: Treatment of central nervous system tumors with methotrexate. Cancer Treat Rpts 65: 137–140, 1981
Kawakami Y, Tabuchi K, Ohnishi T et al.: Primary central nervous system lymphoma. J Neurosurg 62: 522–527, 1985
Mendenhall NP, Thar TL, Ages OF et al.: Primary lymphoma of the nervous system. Cancer 52: 1993–2000, 1983
Letendre L, Banks PM, Reese DR et al.: Primary lymphoma of the central nervous system. Cancer 49: 939–943, 1982
Liu HM, Maurer HS, Vongsivut S, Conway JJ: Methotrexate encephalopathy. Human Pathology 9: 636–649, 1978
Allen JC, Rosen G, Mehta BM, Horten B: Leukoencephalopathy following high dose iv methotrexate chemotherapy with leucovorin rescue. Cancer Treat Rep 64: 1261–1273, 1980
Ackland SP, Schilsky RL: High dose methotrexate: a critical reappraisal. J Clin Oncol 5: 2017–2031, 1987
Pitman SW, Frei E III: Weekly methotrexate-calcium leucovorin rescue: effect of alkalinization on nephrotoxicity; pharmacokinetics in the CNS; and use in CNS non-Hodgkin's lymphoma. Cancer Treat Rep 61: 695–701, 1977
Gabbai AA, Hochberg FH, Linggood R: High dose methotrexate therapy of primary brain lymphoma. J Neurosurg 70: 190–194, 1989
O'Neill BP, Illig JJ: Primary central nervous system lymphoma. Mayo Clin Proc 64: 1005–1020, 1989
Neuwelt EA, Balaban E, Diehl J et al.: Successful treatment of primary central nervous system lymphomas with chemotherapy after osmotic blood-brain barrier opening. Neurosurgery 12: 662–671, 1983
Anders KH, Latta H, Chang B et al.: Lymphomatoid granulomatosis and malignant lymphoma of the central nervous system in the acquired immunodeficiency syndrome. Human Path 20 (4): 326–334, 1989
Starzl TE, Nalesnik MA, Porter KA et al.: Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. The Lancet, March 17, 1984, pp 583–587
Baumgartner JE, Rachlin JR, Beckstead JH et al.: Primary central nervous system lymphomas; Natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg 1991 (in press)
Formenti SC, Parkash SG, Lean E et al.: Primary central nervous system lymphoma in AIDS. Results of radiation therapy. Cancer 63: 1101–1107, 1989
Nobler MP, Leddy ME, Huh SH: The impact of palliative irradiation on the management of patients with aquired immune deficiency syndrome. J Clin Oncol 5: 107–112, 1987
Rechavi BG, Ben-Bassat I, Martinowitz U et al.: Molecular analysis of Burkitt's leukemia in two hemophilic brothers with AIDS. Blood 70 (6): 1713–1717, 1987
Lowenthal DA, Straus DJ, Campbell SW et al.: AIDS-related lymphoid neoplasms. The Memorial Hospital experience. Cancer 61: 2335–2337, 1988
Kaplan LD, Abrams DI, Feigal E et al.: AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 261(5): 719–724, 1989
Gill PB, Levine A, Krailo M et al.: AIDS-related malignant lymphoma: results of prospective treatment trials. J Clin Oncol 5: 1322–1328, 1987
Bashir R, Hochberg FH, Singer RH: Detection of Epstein-Barr Virus by sito hybridization: Progress toward development of a non-isotopic diagnostic test. Amer J Path 135: 1035–1043, 1989
Bashir RM, Harris NL, Hochberg FH, Singer RM: Detection of Epstein-Barr virus in CNS lymphomas by in-situ hybridization. Neurology 39: 813–817, 1989
Hochberg FH, Miller G, Schooley RT: Central nervous system lymphoma related to Epstein-Barr virus. New Engl J Med 309: 745–748, 1983
Rosenberg NL, Hochberg FH, Miller G, Kleinschmidt-Demasters BK: Primary central nervous system lymphoma related to Epstein-Barr virus in a patient with AIDS. Ann Neurol 20: 98–102, 1986
Knowles DM, Inghirami G, Ubraico A, Della-Favera R: Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenic role of Epstein-Barr virus. Blood 73 (3): 792–799, 1989
Blanch S, Le Deist F, Veber F et al.: Treatment of severe Epstein-Barr virus-induced polyclonal B-lymphocyte proliferation by anti-B-cell monoclonal antibodies. Ann Int Med 108: 199–203, 1988
Dimery IW, Jacobs C, Tseng A et al.: Recombinant interferon-gamma in the treatment of recurrent nasopharyngeal carcinoma. J Biol Resp Modifiers 8: 221–226, 1989
Okana M, Thiele GM, Kobayashi RH et al.: Interferongamma in a family with X-linked lymphoproliferative syndrome with acute Epstein-Barr virus infection. J Clin Immun 9 (1): 48–54, 1989
Pirsch JD, Stratta RJ, Sollinger HW et al.: Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with gancyclovir: two cases after solid organ transplantaion. Amer J Med 86: 241–244, 1989
Bashir R, Freedman A, Harris N, Nadler L, Hochberg F: Immunophenotypic profile of CNS lymphoma: a review of eighteen cases. J Neuro-Oncol 7 (3): 249–254, 1989
Garson JA, Bourne SP, Allan PM et al.: Immunohistological diagnosis of primary brain lymphoma using monoclonal antibodies; Confirmation of B cell origin. Neuropath and Applied Neurobio 14: 19–37, 1988
Smith WJ, Garson JA, Bourne SP et al.: Immunoglobulin gene rearrangement and antigenic profile confirm B cell origin of primary cerebral lymphoma and indicate a mature phenotype. J Clin Path 41: 128–132, 1988
Lashford LS, Davies RB et al.: A pilot study of I-131 monoclonal antibodies in the therapy of leptomeningeal tumors. Cancer 61: 857–868, 1988
Coakham HB, Richardson RB et al.: Neoplastic meningitis from a pineal tumor treated by antibody-guided irradiation via the intrathecal route. Brit J Neurosurg 2: 193–204, 1988
Brown SL, Miller RA, Horning SJ et al.: Treatment of B cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon. Blood 73 (3): 651–661, 1989
Meeker TC, Lowder J, Maloney DG et al.: A clinical trial of anti-idiotype therapy for B cell malignancy. Blood 65: 1349–1363, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hochberg, F.H., Loeffler, J.S. & Prados, M. The therapy of primary brain lymphoma. J Neuro-Oncol 10, 191–201 (1991). https://doi.org/10.1007/BF00177531
Issue Date:
DOI: https://doi.org/10.1007/BF00177531